Bonus Biogroup Ltd. is a biotechnology company, which engages in the field of stem cells and tissue engineering. The firm is developing cell therapy products based on autologous and allogeneic bone implants that will enable efficient bone transplant and provide cellular-based bone replacement prosthetics for repairing bone lesions. The company is targeting a worldwide market for the treatment of major disorders such as bone and cartilage related arthritis, osteoporosis, and various types of bones and joint trauma such as hip fractures and knee injuries, among others. On April 29, 2012, Bonus Bio Group Ltd fully acquired Bonus Therapeutic Ltd.
BBIXF stock price ended at $0.08 on 목요일, after rising 300.00%
On the latest trading day Oct 30, 2025, the stock price of BBIXF rose by 300.00%, climbing from $0.08 to $0.08. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.08 and a high of $0.08. Alongside this price increase, trading volume also rose by 6.5K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 3.4K shares were traded, amounting to a market value of approximately $93.4M.
BBIXF 기술적 시그널
기술적 시그널 요약
구매 신호 2
중립 신호 3
매도 신호 2
Strong Sell
Sell
Neutral
Buy
Strong Buy
BBIXF은 현재 2개의 매수 신호와 2개의 매도 신호를 보이고 있습니다. 이 주식은 12:00 AM 이후로 상승 추세 상태에 있으며, 이 기간 동안 총 가격 변동률은 Infinity%입니다. 전반적으로 기술적 지표들은 중기적으로 Neutral 전망을 나타내고 있습니다.
BBIXF에 대한 강세/약세 신호
이동평균, RSI, MACD, 거래량 등 핵심 지표를 분석하여 BBIXF 의 강세/약세 시그널을 생성합니다. 이 인사이트를 활용해 더 현명한 투자 결정을 내리세요.